Status:
RECRUITING
Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Non-Alcoholic Fatty Liver Disease
Obesity, Morbid
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study is aimed * To quantify the change of adipose tissues, triglyceride in liver and pancreas and cholesterol after lifestyle intervention or bariatric surgery. * To test the hypothesis that Bro...
Detailed Description
Obesity is associated with different chronic disorders such as metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and diabetes mellitus type 2 (DM2). It can be classified into mild, moderat...
Eligibility Criteria
Inclusion
- BMI ≥ 25-30 kg/m2
- BMI ≥ 30 kg/m2 with Metabolic syndrome
- BMI ≥ 35 kg/m2 for morbid obesity
Exclusion
- Other kind of hepatic diseases
- Under medications known to affect liver fat
- Waist circumference ≥ 150 cm
- Weight ≥ 250 kg
- MRI contraindications
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03875625
Start Date
April 1 2019
End Date
June 30 2026
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong, Prince of Wale Hospital
Hong Kong, Shatin, Hong Kong